L&K Biomed Ltd. (KOSDAQ:156100)

L&K Biomed Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 8, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	170,092	272,576	132,181	202,956	107,379	143,972
Market Cap Growth	28.10%	106.21%	-34.87%	89.01%	-25.42%	-71.54%
Enterprise Value	176,112	278,305	129,243	200,512	115,624	150,234
Last Close Price	7610.00	12960.00	6630.00	10180.00	7212.36	9679.51
PE Ratio	-	-	13.57	-	-	-
Forward PE	-	25.02	25.02	25.02	25.02	25.02
PS Ratio	4.37	7.00	3.66	6.79	5.43	9.37
PB Ratio	4.40	7.06	3.67	6.64	9.98	5.81
P/TBV Ratio	3.83	6.14	3.19	5.87	9.29	6.19
EV/Sales Ratio	4.52	7.15	3.58	6.71	5.85	9.77
EV/EBITDA Ratio	53.41	79.58	22.88	46.12	-	-
EV/EBIT Ratio	-	389.17	41.99	98.58	-	-
Debt / Equity Ratio	0.50	0.50	0.65	0.44	2.34	0.91
Debt / EBITDA Ratio	5.47	5.47	4.14	3.11	-	-
Net Debt / Equity Ratio	0.33	0.33	0.10	0.02	1.13	0.13
Net Debt / EBITDA Ratio	3.68	3.68	0.61	0.17	-1.17	-0.24
Net Debt / FCF Ratio	-0.76	-0.76	-0.43	-0.22	-1.82	-0.31
Asset Turnover	0.47	0.47	0.50	0.52	0.35	0.26
Inventory Turnover	0.23	0.23	0.27	0.24	0.33	0.48
Quick Ratio	0.65	0.65	0.90	1.04	0.50	1.70
Current Ratio	1.60	1.60	1.63	1.95	0.95	3.01
Return on Equity (ROE)	-44.98%	-44.98%	27.47%	-25.34%	-91.33%	-46.30%
Return on Assets (ROA)	0.54%	0.54%	2.64%	2.20%	-14.22%	-16.15%
Return on Invested Capital (ROIC)	1.35%	1.57%	8.11%	7.49%	-49.97%	-41.32%
Return on Capital Employed (ROCE)	1.60%	1.60%	7.00%	5.10%	-86.80%	-32.70%
Earnings Yield	-9.58%	-5.98%	7.37%	-0.92%	-12.69%	-6.72%
FCF Yield	-9.92%	-6.19%	-6.06%	-1.68%	-6.22%	-7.29%
Buyback Yield / Dilution	6.57%	6.57%	-34.13%	-21.04%	-0.07%	-12.57%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.